Background SSRI (Selective Serotonin Reuptake Inhibitors) are the most frequent drugs to treat depression during pregnancy (16% prevalence in Italy), but they have direct potential effects on the developing embryo including abortion, growth restriction, preterm birth, malformations and neonatal complications. The aim of our study was to investigate the contribution of pharmacokinetics and pharmacogenetics approach on infants outcome. Methods We performed a case-control study: cases (n. 43) were caucasian women with a diagnosis of depression and/or anxiety, in treatment with SSRI for the whole pregnancy. Controls (n. 86) were caucasian women without a psychiatric diagnosis and not exposed to SSRIs during pregnancy. Exclusion criteria for b...
Depression is common in reproductive age women, and continued pharmacologic treatment of depression ...
BACKGROUND: Intrauterine exposure to antidepressants may lead to neonatal symptoms from the central ...
Maternal use of SSRIs for depression and anxiety during pregnancy has increased over the last decade...
Background: An involvement of selective serotonin reuptake inhibitors (SSRIs) in increasing the risk...
Lots has been written on use of SSRI during pregnancy and possible short and long term negative outc...
Lots has been written on use of SSRI during pregnancy and possible short and long term negative outc...
Copyright © 2014 Valentina Giudici et al. This is an open access article distributed under the Creat...
OBJECTIVE: This study aimed to investigate neonatal outcomes after prenatal exposure to selective se...
OBJECTIVES: To estimate the rate of admissions to NICUs, as well as infants' morbidity and abs neona...
Use of selective serotonin reuptake inhibitors (SSRI) during pregnancy is common while the effect on...
Little is known concerning possible hazards of maternal use of the recently introduced antidepressan...
Over the last few years, several reports on the safety of antidepressants use in pregnancy have been...
This study investigated the role of prenatal Selective Serotonin Reuptake Inhibitors (SSRIs) on infa...
Background: Experimental animal studies and one population-based study have suggested an increased r...
Background: Use of selective serotonin reuptake inhibitors (SSRI) during pregnancy is common while t...
Depression is common in reproductive age women, and continued pharmacologic treatment of depression ...
BACKGROUND: Intrauterine exposure to antidepressants may lead to neonatal symptoms from the central ...
Maternal use of SSRIs for depression and anxiety during pregnancy has increased over the last decade...
Background: An involvement of selective serotonin reuptake inhibitors (SSRIs) in increasing the risk...
Lots has been written on use of SSRI during pregnancy and possible short and long term negative outc...
Lots has been written on use of SSRI during pregnancy and possible short and long term negative outc...
Copyright © 2014 Valentina Giudici et al. This is an open access article distributed under the Creat...
OBJECTIVE: This study aimed to investigate neonatal outcomes after prenatal exposure to selective se...
OBJECTIVES: To estimate the rate of admissions to NICUs, as well as infants' morbidity and abs neona...
Use of selective serotonin reuptake inhibitors (SSRI) during pregnancy is common while the effect on...
Little is known concerning possible hazards of maternal use of the recently introduced antidepressan...
Over the last few years, several reports on the safety of antidepressants use in pregnancy have been...
This study investigated the role of prenatal Selective Serotonin Reuptake Inhibitors (SSRIs) on infa...
Background: Experimental animal studies and one population-based study have suggested an increased r...
Background: Use of selective serotonin reuptake inhibitors (SSRI) during pregnancy is common while t...
Depression is common in reproductive age women, and continued pharmacologic treatment of depression ...
BACKGROUND: Intrauterine exposure to antidepressants may lead to neonatal symptoms from the central ...
Maternal use of SSRIs for depression and anxiety during pregnancy has increased over the last decade...